... and conducted pioneering work in microRNA biology at Ionis Pharmaceuticals and Regulus Therapeutics.
Grateful to have Christine on our team as we advance transformative RNA therapies for patients with brain disease!
Welcoming Christine Esau to our SAB. She is a former Group Vice President at Arrowhead Pharmaceuticals, where she led the development of their CNS-targeted siRNA programs 🧠🧬
Christine was the original site head for the company's San Diego research site, where she established its biology drug discovery functions and developed a portfolio of CNS programs. Before Arrowhead, she held senior roles at Genevant Sciences & Arcturus Therapeutics...